← Back to Clinical Trials
Recruiting NCT07212283

NCT07212283 Wise Intervention for Reducing Aggressive Behaviors and Promoting Prosocial Behaviors Toward LGB-TNB Individuals

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07212283
Status Recruiting
Phase
Sponsor University of Deusto
Condition Aggression
Study Type INTERVENTIONAL
Enrollment 1,000 participants
Start Date 2025-09-18
Primary Completion 2026-06

Trial Parameters

Condition Aggression
Sponsor University of Deusto
Study Type INTERVENTIONAL
Phase N/A
Enrollment 1,000
Sex ALL
Min Age 14 Years
Max Age 18 Years
Start Date 2025-09-18
Completion 2026-06
Interventions
Wise Intervention LGB-TNBValues alignment wise intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study evaluates the effectiveness of a wise Intervention to reduce aggressive behaviors and promote prosocial behaviors toward LGB-TNB individuals among Spanish adolescents. Half of the participants will receive the experimental intervention, while the other half will receive a control intervention.

Eligibility Criteria

Inclusion Criteria: * Informed consent by the adolescents and their families. * To be fluent in Spanish and/or Euskera. Exclusion Criteria: * Lack of permission by families and the adolescent. * Lack of understanding of the instructions.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology